Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
8.34M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
78.7K
-
Shares change
-
+1.54K
-
Total reported value, excl. options
-
$99.1K
-
Value change
-
-$117K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$1.30
Significant Holders of Pasithea Therapeutics Corp. - Common Stock, $0.0001 par value per share (KTTA) as of Q1 2025
10 filings reported holding KTTA - Pasithea Therapeutics Corp. - Common Stock, $0.0001 par value per share as of Q1 2025.
Pasithea Therapeutics Corp. - Common Stock, $0.0001 par value per share (KTTA) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.7K shares
of 8.34M outstanding shares and own 0.94% of the company stock.
Largest 10 shareholders include AdvisorShares Investments LLC (53.5K shares), CITIGROUP INC (13.7K shares), UBS Group AG (4.34K shares), Hurley Capital, LLC (3.69K shares), Tower Research Capital LLC (TRC) (3.27K shares), JPMORGAN CHASE & CO (150 shares), BANK OF AMERICA CORP /DE/ (8 shares), MORGAN STANLEY (0 shares), ARMISTICE CAPITAL, LLC (0 shares), and ROYAL BANK OF CANADA (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.